Exhibit 10.1

Nordicus Partners Corporation
Director Agreement

This Director Agreement (this “Agreement”) is entered into as of August 7, 2025, by and between Nordicus Partners Corporation, a Delaware corporation (the “Company”), Torben Jensen (the “Director”).

The Company hereby appoints Director to serve as a member of the Board of Directors of the Company (the “Board”) for the term set forth in the Company’s governing documents, subject to re-election in accordance with applicable laws and the Company’s bylaws. Director hereby accepts such appointment.

(a) Director agrees to faithfully, diligently, and to the best of his ability serve as a director of the Company and, if applicable, as a member of one or more committees of the Board, subject to the terms and conditions of this Agreement, the Company’s governing documents, applicable law, and the rules of The Nasdaq Stock Market LLC (“Nasdaq”) and the OTCQB Market (“OTCQB”).

(b) Director will comply with all applicable laws, the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”), the rules of the OTCQB or Nasdaq, as applicable, and the Company’s corporate governance policies, including the Code of Ethics, Corporate Governance Guidelines, Insider Trading Policy, and any other applicable policies.

(c) Director acknowledges and agrees to comply with the U.S. Securities Exchange Act of 1934, including Sections 10(b) and 16, and related SEC rules on insider trading and reporting (e.g., Forms 3, 4, and 5) and the Company’s Insider Trading Policy, including blackout periods and pre-clearance requirements.

(d) Director understands that material non-public information may not be used for personal gain or disclosed improperly.

(e) Director will devote sufficient time to fulfill his duties as a director, including attending Board meetings and applicable committee meetings. Director shall exercise the duties of loyalty, care, and good faith as required under applicable corporate law.

(f) Director shall qualify as an “independent director” as defined in Nasdaq Listing Rule 5605(a)(2) (unless otherwise agreed).

This Agreement shall remain in effect for the duration of Director’s service on the Board, unless terminated earlier pursuant to Section 7.

Director shall receive compensation as set forth in the Company’s applicable compensation policies for non-employee directors, which currently include:

(a) Annual cash retainer of $10,000, payable in two installments per calendar year.

(b) Equity compensation in the form of stock options, restricted stock units (RSUs), or other awards, subject to the terms of the applicable equity incentive plan. In particular, the Company agrees to grant you options to purchase 25,000 shares of Corporation’s common stock (the “Option Shares”), at an exercise price of $1.90 per share (the “Options”), which shall expire ten years from the date of this agreement.

(i) The Options shall be issued as Incentive Stock Options under and be otherwise subject to the terms and conditions of, the Company’s 2024 Stock Incentive Plan (the “Plan”) and the Company’s standard Stock Option Agreement, as modified by this agreement. During the term of this agreement, you may be granted additional stock options or other equity rights, as determined by Corporation’s Compensation Committee, in its sole discretion.

(ii) The Options be fully vested on the date of grant.

(iii) When the Options expire, any unexercised Options can no longer be exercised in whole or in part.

(c) Reimbursement of reasonable out-of-pocket expenses incurred in connection with service on the Board, including travel expenses for attending meetings.

Director acknowledges and agrees to maintain the confidentiality of all non-public information regarding the Company, its subsidiaries, affiliates, and customers, obtained as a result of their service on the Board, both during and after the term of service. This obligation survives the termination of this Agreement.

The Company agrees to: (a) indemnify Director to the fullest extent permitted by applicable law, the Company’s Certificate of Incorporation, and Bylaws; and (b) enter into a separate Indemnification Agreement, which is incorporated herein by reference.

(a) Director shall assist the Company in complying with Nasdaq corporate governance standards, including:

(i) Periodic independence determinations.

(ii) Committee membership requirements under Nasdaq Rule 5605(c) (Audit Committee) and 5605(d) (Compensation Committee), as applicable.

(iii) Filing obligations under SEC rules and Nasdaq’s Listing Rule 5250 (Disclosure Obligations).

(b) Director shall promptly notify the Company if any event arises that may affect their independence status, eligibility, or capacity to serve.

This Agreement shall terminate upon the earliest of:

(a) Director’s resignation or removal from the Board.

(b) Director’s failure to be re-elected to the Board.

(c) Director’s death or incapacity.

(d) Mutual written agreement of the parties.

The Company shall indemnify Director to the fullest extent permitted by law and the Company’s charter and bylaws. The Company shall maintain directors’ and officers’ (D&O) liability insurance covering Director during the term of service and for a reasonable period thereafter.

Director acknowledges and agrees that they owe fiduciary duties to the Company and its shareholders, including the duties of care, loyalty, and good faith.

This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflicts of law principles.

This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements or understandings, whether written or oral.

Any amendments or modifications to this Agreement must be in writing and signed by both parties.

IN WITNESS WHEREOF, the parties have executed this Director Agreement as of the date first written above.

Exhibit 10.2

Nordicus Partners Corporation
Director Agreement

This Director Agreement (this “Agreement”) is entered into as of August 7, 2025, by and between Nordicus Partners Corporation, a Delaware corporation (the “Company”), and Kim T. Mücke (the “Director”).

The Company hereby appoints Director to serve as a member of the Board of Directors of the Company (the “Board”) for the term set forth in the Company’s governing documents, subject to re-election in accordance with applicable laws and the Company’s bylaws. Director hereby accepts such appointment.

(a) Director agrees to faithfully, diligently, and to the best of his ability serve as a director of the Company and, if applicable, as a member of one or more committees of the Board, subject to the terms and conditions of this Agreement, the Company’s governing documents, applicable law, and the rules of The Nasdaq Stock Market LLC (“Nasdaq”) and the OTCQB Market (“OTCQB”).

(b) Director will comply with all applicable laws, the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”), the rules of the OTCQB or Nasdaq, as applicable, and the Company’s corporate governance policies, including the Code of Ethics, Corporate Governance Guidelines, Insider Trading Policy, and any other applicable policies.

(c) Director acknowledges and agrees to comply with the U.S. Securities Exchange Act of 1934, including Sections 10(b) and 16, and related SEC rules on insider trading and reporting (e.g., Forms 3, 4, and 5) and the Company’s Insider Trading Policy, including blackout periods and pre-clearance requirements.

(d) Director understands that material non-public information may not be used for personal gain or disclosed improperly.

(e) Director will devote sufficient time to fulfill his duties as a director, including attending Board meetings and applicable committee meetings. Director shall exercise the duties of loyalty, care, and good faith as required under applicable corporate law.

(f) Director shall qualify as an “independent director” as defined in Nasdaq Listing Rule 5605(a)(2) (unless otherwise agreed).

This Agreement shall remain in effect for the duration of Director’s service on the Board, unless terminated earlier pursuant to Section 7.

Director shall receive compensation as set forth in the Company’s applicable compensation policies for non-employee directors, which currently include:

(a) Annual cash retainer of $10,000, payable in two installments per calendar year.

(b) Equity compensation in the form of stock options, restricted stock units (RSUs), or other awards, subject to the terms of the applicable equity incentive plan. In particular, the Company agrees to grant you options to purchase 25,000 shares of Corporation’s common stock (the “Option Shares”), at an exercise price of $1.90 per share (the “Options”), which shall expire ten years from the date of this agreement.

(i) The Options shall be issued as Incentive Stock Options under and be otherwise subject to the terms and conditions of, the Company’s 2024 Stock Incentive Plan (the “Plan”) and the Company’s standard Stock Option Agreement, as modified by this agreement. During the term of this agreement, you may be granted additional stock options or other equity rights, as determined by Corporation’s Compensation Committee, in its sole discretion.

(ii) The Options be fully vested on the date of grant.

(iii) When the Options expire, any unexercised Options can no longer be exercised in whole or in part.

(c) Reimbursement of reasonable out-of-pocket expenses incurred in connection with service on the Board, including travel expenses for attending meetings.

Director acknowledges and agrees to maintain the confidentiality of all non-public information regarding the Company, its subsidiaries, affiliates, and customers, obtained as a result of their service on the Board, both during and after the term of service. This obligation survives the termination of this Agreement.

The Company agrees to: (a) indemnify Director to the fullest extent permitted by applicable law, the Company’s Certificate of Incorporation, and Bylaws; and (b) enter into a separate Indemnification Agreement, which is incorporated herein by reference.

(a) Director shall assist the Company in complying with Nasdaq corporate governance standards, including:

(i) Periodic independence determinations.

(ii) Committee membership requirements under Nasdaq Rule 5605(c) (Audit Committee) and 5605(d) (Compensation Committee), as applicable.

(iii) Filing obligations under SEC rules and Nasdaq’s Listing Rule 5250 (Disclosure Obligations).

(b) Director shall promptly notify the Company if any event arises that may affect their independence status, eligibility, or capacity to serve.

This Agreement shall terminate upon the earliest of:

(a) Director’s resignation or removal from the Board.

(b) Director’s failure to be re-elected to the Board.

(c) Director’s death or incapacity.

(d) Mutual written agreement of the parties.

The Company shall indemnify Director to the fullest extent permitted by law and the Company’s charter and bylaws. The Company shall maintain directors’ and officers’ (D&O) liability insurance covering Director during the term of service and for a reasonable period thereafter.

Director acknowledges and agrees that they owe fiduciary duties to the Company and its shareholders, including the duties of care, loyalty, and good faith.

This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflicts of law principles.

This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements or understandings, whether written or oral.

Any amendments or modifications to this Agreement must be in writing and signed by both parties.

IN WITNESS WHEREOF, the parties have executed this Director Agreement as of the date first written above.

Exhibit 10.3

Nordicus Partners Corporation
Director Agreement

This Director Agreement (this “Agreement”) is entered into as of August 7, 2025, by and between Nordicus Partners Corporation, a Delaware corporation (the “Company”), and Andrew Ritter (the “Director”).

The Company hereby appoints Director to serve as a member of the Board of Directors of the Company (the “Board”) for the term set forth in the Company’s governing documents, subject to re-election in accordance with applicable laws and the Company’s bylaws. Director hereby accepts such appointment.

(a) Director agrees to faithfully, diligently, and to the best of his ability serve as a director of the Company and, if applicable, as a member of one or more committees of the Board, subject to the terms and conditions of this Agreement, the Company’s governing documents, applicable law, and the rules of The Nasdaq Stock Market LLC (“Nasdaq”) and the OTCQB Market (“OTCQB”).

(b) Director will comply with all applicable laws, the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”), the rules of the OTCQB or Nasdaq, as applicable, and the Company’s corporate governance policies, including the Code of Ethics, Corporate Governance Guidelines, Insider Trading Policy, and any other applicable policies.

(c) Director acknowledges and agrees to comply with the U.S. Securities Exchange Act of 1934, including Sections 10(b) and 16, and related SEC rules on insider trading and reporting (e.g., Forms 3, 4, and 5) and the Company’s Insider Trading Policy, including blackout periods and pre-clearance requirements.

(d) Director understands that material non-public information may not be used for personal gain or disclosed improperly.

(e) Director will devote sufficient time to fulfill his duties as a director, including attending Board meetings and applicable committee meetings. Director shall exercise the duties of loyalty, care, and good faith as required under applicable corporate law.

(f) Director shall qualify as an “independent director” as defined in Nasdaq Listing Rule 5605(a)(2) (unless otherwise agreed).

This Agreement shall remain in effect for the duration of Director’s service on the Board, unless terminated earlier pursuant to Section 7.

Director shall receive compensation as set forth in the Company’s applicable compensation policies for non-employee directors, which currently include:

(a) Annual cash retainer of $10,000, payable in two installments per calendar year.

(b) Equity compensation in the form of stock options, restricted stock units (RSUs), or other awards, subject to the terms of the applicable equity incentive plan. In particular, the Company agrees to grant you options to purchase 50,000 shares of Corporation’s common stock (the “Option Shares”), at an exercise price of $1.90 per share (the “Options”), which shall expire ten years from the date of this agreement.

(i) The Options shall be issued as Incentive Stock Options under and be otherwise subject to the terms and conditions of, the Company’s 2024 Stock Incentive Plan (the “Plan”) and the Company’s standard Stock Option Agreement, as modified by this agreement. During the term of this agreement, you may be granted additional stock options or other equity rights, as determined by Corporation’s Compensation Committee, in its sole discretion.

(ii) The Options be fully vested on the date of grant.

(iii) When the Options expire, any unexercised Options can no longer be exercised in whole or in part.

(c) Reimbursement of reasonable out-of-pocket expenses incurred in connection with service on the Board, including travel expenses for attending meetings.

Director acknowledges and agrees to maintain the confidentiality of all non-public information regarding the Company, its subsidiaries, affiliates, and customers, obtained as a result of their service on the Board, both during and after the term of service. This obligation survives the termination of this Agreement.

The Company agrees to: (a) indemnify Director to the fullest extent permitted by applicable law, the Company’s Certificate of Incorporation, and Bylaws; and (b) enter into a separate Indemnification Agreement, which is incorporated herein by reference.

(a) Director shall assist the Company in complying with Nasdaq corporate governance standards, including:

(i) Periodic independence determinations.

(ii) Committee membership requirements under Nasdaq Rule 5605(c) (Audit Committee) and 5605(d) (Compensation Committee), as applicable.

(iii) Filing obligations under SEC rules and Nasdaq’s Listing Rule 5250 (Disclosure Obligations).

(b) Director shall promptly notify the Company if any event arises that may affect their independence status, eligibility, or capacity to serve.

This Agreement shall terminate upon the earliest of:

(a) Director’s resignation or removal from the Board.

(b) Director’s failure to be re-elected to the Board.

(c) Director’s death or incapacity.

(d) Mutual written agreement of the parties.

The Company shall indemnify Director to the fullest extent permitted by law and the Company’s charter and bylaws. The Company shall maintain directors’ and officers’ (D&O) liability insurance covering Director during the term of service and for a reasonable period thereafter.

Director acknowledges and agrees that they owe fiduciary duties to the Company and its shareholders, including the duties of care, loyalty, and good faith.

This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to conflicts of law principles.

This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements or understandings, whether written or oral.

Any amendments or modifications to this Agreement must be in writing and signed by both parties.

IN WITNESS WHEREOF, the parties have executed this Director Agreement as of the date first written above.

Exhibit 99.1

Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors

Beverly Hills, California, August 7, 2025…Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a business accelerator and holding company specializing in providing Nordic and U.S. life sciences companies with optimal conditions to establish themselves on the U.S. market, announced today that Henrik Keller resigned from the Board of Directors (the “Board”) of Nordicus to pursue other interests; that the Board has been increased from three to five members; and that Torben Jensen, Kim T. Mücke and Andrew J. Ritter have been appointed to fill the vacancies on the Board.

“We thank Henrik Keller for his service to our company,” said Henrik Rouf, CEO of Nordicus, “and welcome our three new board members. Mr. Jensen is already a major shareholder and will continue to provide valuable assistance in funding Nordicus and its subsidiaries. Mr. Mücke brings us many years of experience in the accounting industry and will play a key role as chairman of our Board’s Audit Committee. Mr. Ritter is an experienced CEO of public companies in the pharma space and will be invaluable in assisting us in both corporate finance and establishing strategic relationships with potential acquirers of our products. All three will be invaluable to Nordicus as we pursue our mission to acquire majority stakes in Nordic- as well as U.S.-based life sciences companies.”

About Torben Jensen

Torben Jensen (60) has more than 35 years of experience in finance and has during the years developed and funded projects and companies in real estate, energy, venture, life science and medico. He has previously been CEO and Chairman of the Board of two listed companies on Nasdaq. From 2019 to 2024 he was a Senior Partner in GK Partners ApS, a corporate finance house and a major shareholder in Nordicus, where he was the head of funding for projects. Furthermore, he has served as the Chief Executive Officer of AC Nordic since December 2024, also a major shareholder in Nordicus.

About Kim T. Mücke

Kim T. Mücke is a Danish state authorized public accountant (authorization deposited in 2025). He was partner with Deloitte (Denmark) from 2002 to 2022 where he, among others, served as signing partner for various listed companies including companies that underwent IPO processes. In the years 2023-2024, Mr. Mücke was Head of Corporate Clients for BDO (Denmark). From January 1, 2025, Mr. Mücke has started as independent advisor, specialized in financial reporting, risk management and corporate governance. Mr. Mücke has a master’s degree in Auditing and Accounting from the Copenhagen Business School.

About Andrew J. Ritter

Andrew J. Ritter has served as the Chief Executive Officer and a director of Cairns Health, an innovator in AI-powered remote care solutions supporting home and senior care, since September 2023. Previously, Mr. Ritter was the Chief Executive Officer of Docbot, an AI-driven MedTech company, from January 2021 to December 2022. He also founded and served as Chief Executive Officer of Ritter Pharmaceuticals, a biotechnology company focusing on gastrointestinal diseases, from March 2004 to May 2020. In addition, he served as a founding director of Myosin Therapeutics, a biotech spin-out from Scripps Research, from October 2021 to January 2025. Mr. Ritter earned a B.A. in political science at the University of Southern California and a Master of Business Administration at the Wharton School, University of Pennsylvania.

About Nordicus Partners Corporation

Nordicus Partners Corporation is the only U.S. publicly traded business accelerator and holding company for Nordic life sciences companies. Leveraging decades of combined management experience in domestic and global corporate sectors, Nordicus excels in corporate finance activities including business and market development, growth strategies, talent acquisition, partnership building, capital raising, and facilitating company acquisitions and sales. In 2024, Nordicus acquired 100% of Orocidin A/S, a Danish preclinical-stage biotech company developing next-generation therapies for periodontitis and 100% of Bio-Convert A/S, a Danish preclinical-stage biotech company dedicated to revolutionizing the treatment of oral leukoplakia. For more information about Nordicus, please visit: www.nordicuspartners.com, and follow us at www.nordicuspartners.com, and follow us on LinkedIn, X, Threads and BlueSky.

Forward-Looking Statements

This press release may contain forward-looking statements that involve substantial risks and uncertainties. You can identify these statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expect,” “anticipate,” “project,” “estimate,” “intend,” “continue” or “believe” or the negatives thereof or other variations thereon or comparable terminology. You should read statements that contain these words carefully because they discuss our plans, strategies, prospects and expectations concerning our business, operating results, financial condition and other similar matters. We believe that it is important to communicate our future expectations to our investors. There may be events in the future, however, that we are not able to predict accurately or control. Any forward-looking statement made by us in this press release speaks only as of the date on which we make it. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

For further information contact

Mr. Henrik Rouf

Chief Executive Officer

Phone +1 310 666.0750

Email [email protected]